Tongji Hospital

This study is testing whether a drug called baricitinib is better than the standard treatment (cyclophosphamide) at reducing skin thickening and improving symptoms in people with early, severe systemic sclerosis. It involves 60 adults who will take the assigned medication for 48 …

This study is testing whether a daily medication called Desvenlafaxine can help prevent frequent tension headaches in adults. Over 400 participants with frequent episodic headaches will take either the real drug or a placebo pill for 12 weeks to see if it reduces how many headach…

This study aims to understand how well the medication tofacitinib works for people with Blau Syndrome, a rare genetic inflammatory disease. Researchers will look back at the medical records of 24 patients to see how their symptoms responded to treatment. They will also check if s…

This study is testing whether the medication desvenlafaxine can help prevent frequent migraine attacks. It involves 440 adults who get migraines several times a month. Researchers will measure if taking the drug for 12 weeks reduces how often people get migraines and how bad they…

This study is testing whether a computer program (machine learning model) can accurately predict which liver cancer patients are at high risk of their cancer spreading to other organs like the lungs or bones after initial treatment. It involves 800 patients who have already had t…

This study aims to learn more about how Crohn's disease affects children by observing about 100 patients under 17 years old for up to two years. Researchers will track their symptoms, the different treatments their doctors prescribe, and how well they do over time. The goal is to…